Supernus, Inc. (INDV) stock
INDVNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SUPN
$35.37+0.12 (+0.34%)
Close on Oct 30, 2026Market cap $4.17BP/E 9.9Yield –
Supernus cash
Cash and short-term investments held at the end of each period.
Supernus's cash was $305.00M at Sep 30, 2026. For fiscal 2025 it was $195.00M, down 39.1% from the year before. The highest annual figure on record is $1.10B in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $195.00M | -39.1% |
| FY2024 | Dec 31, 2024 | $320.00M | -22.0% |
| FY2023 | Dec 31, 2023 | $410.00M | -47.0% |
| FY2022 | Dec 31, 2022 | $774.00M | -29.8% |
| FY2021 | Dec 31, 2021 | $1.10B | +28.4% |
| FY2020 | Dec 31, 2020 | $858.00M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $305.00M | -31.5% |
| Q2 FY2026 | Jun 30, 2026 | $222.00M | -56.5% |
| Q1 FY2026 | Mar 31, 2026 | $175.00M | -53.1% |
| Q4 FY2025 | Dec 31, 2025 | $195.00M | -39.1% |
| Q3 FY2025 | Sep 30, 2025 | $445.00M | +54.5% |
| Q2 FY2025 | Jun 30, 2025 | $510.00M | +68.9% |
| Q1 FY2025 | Mar 31, 2025 | $373.00M | +50.4% |
| Q4 FY2024 | Dec 31, 2024 | $320.00M | -22.0% |
| Q3 FY2024 | Sep 30, 2024 | $288.00M | -62.8% |
| Q2 FY2024 | Jun 30, 2024 | $302.00M | -72.6% |
| Q1 FY2024 | Mar 31, 2024 | $248.00M | -71.1% |
| Q4 FY2023 | Dec 31, 2023 | $410.00M | – |
| Q4 FY2022 | Dec 31, 2022 | $774.00M | – |
| Q4 FY2021 | Dec 31, 2021 | $1.10B | – |
| Q4 FY2020 | Dec 31, 2020 | $858.00M | – |
See a number that looks wrong?